Skip to main content
D. Arizona· 8/21/2013

Ramirez v. Medtronic Inc.

Citations

  • 961 F. Supp. 2d 977
  • 2013 WL 4446913
  • 2013 U.S. Dist. LEXIS 118822

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • holding that Riegel’,s shield drops if plaintiff alleges off-label promotion and that most claims, including design defect claims, evade preemption
  • finding that patient’s express warranty claim against distant manufacturer could not survive because representations came from intermediary doctor only
  • following Stengel and declining to dismiss a “failure to warn” claim premised on defendants’ failure to report adverse events involving Infuse to the FDA
  • finding that the concerns underlying section 360k’s express preemption provision “vanish[ ] when the plaintiff brings a claim against a manufacturer that arises out of a use that has not been reviewed by the FDA but has been promoted by the manufacturer”
  • declining to take judicial notice of same exhibit as in this action
  • dismissing breach of express warranty claim because “any affirmation that forms the basis of an express warranty must be between the seller and the buyer” and Ramirez “does not allege (in anything other than the most conclusory manner

Source: CourtListener parenthetical corpus (CC0).

Judges: Snow

Read full opinion on CourtListener

Cited by

26 cases in this archive cite this case; the 20 most cited are listed.

Cites

41 cases in this archive are cited by this case; the 20 most cited are listed.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.